Skip to main content
. Author manuscript; available in PMC: 2017 Aug 8.
Published in final edited form as: Arthritis Rheumatol. 2016 Mar;68(3):597–603. doi: 10.1002/art.39468

Table 1.

Medication name, risk conferred, and frequency and percentage of patients in the sample*

Medication name Risk Frequency Percent
Azathioprine High 34 5.38
Budesonide Low 34 5.38
Budesonide inhaled formulations Low 23 3.64
Chloroquine Low 1 0.16
Cyclosporine High 9 1.42
Hydroxychloroquine Low 65 10.28
Leflunomide High 46 7.27
Mercaptopurine High 28 4.43
Mesalamine Low 81 12.81
Methotrexate High 245 38.77
Penicillamine Low 1 0.16
Prednisone 264 41.77
Sulfasalazine Low 42 6.65
Ustekinumab High 1 0.16
*

A total of 203 patients were not taking any medications.

During the analysis, prednisone was not classified as “high” or “low” risk but was analyzed separately.